Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sanofi-Aventis S.A. ADR (SNY)

Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 122,154,720
  • Shares Outstanding, K 2,529,607
  • Annual Sales, $ 50,266 M
  • Annual Income, $ 5,844 M
  • 60-Month Beta 0.61
  • Price/Sales 2.61
  • Price/Cash Flow 7.52
  • Price/Book 1.51
Trade SNY with:

Options Overview Details

View History
  • Implied Volatility 17.79% ( -1.44%)
  • Historical Volatility 13.61%
  • IV Percentile 4%
  • IV Rank 11.12%
  • IV High 30.43% on 10/27/23
  • IV Low 16.21% on 08/23/23
  • Put/Call Vol Ratio 0.48
  • Today's Volume 291
  • Volume Avg (30-Day) 649
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 26,554
  • Open Int (30-Day) 28,138

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.99
  • Number of Estimates 2
  • High Estimate 0.99
  • Low Estimate 0.98
  • Prior Year 1.16
  • Growth Rate Est. (year over year) -14.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.84 +2.11%
on 03/04/24
48.94 -2.27%
on 02/28/24
+1.65 (+3.57%)
since 02/16/24
3-Month
45.55 +5.01%
on 02/13/24
52.79 -9.40%
on 01/12/24
-0.71 (-1.46%)
since 12/18/23
52-Week
42.63 +12.20%
on 10/27/23
57.82 -17.28%
on 04/26/23
+0.09 (+0.19%)
since 03/17/23

Most Recent Stories

More News
Beyond the GRANOLAS: JPMorgan Picks 3 Top Stocks to Bet on Europe

The renowned brokerage firm weighed in on its top stock picks from the European market, which could offer investors better value than the outsized GRANOLAS group of equities at current levels.

NVDA : 884.55 (+0.70%)
MSFT : 417.32 (+0.22%)
AMZN : 174.48 (+0.03%)
AAPL : 173.72 (+0.64%)
META : 496.98 (+2.66%)
GOOGL : 147.68 (+4.60%)
TSLA : 173.80 (+6.25%)
GS : 384.37 (-0.73%)
GSK : 42.14 (-0.12%)
RHHBY : 32.1800 (-1.41%)
NSRGY : 106.3900 (-1.38%)
NVS : 95.92 (-1.39%)
2 Healthcare Stocks You Can Buy and Hold for the Next Decade

Don't count these companies out too soon.

MDT : 83.66 (+0.11%)
SNY : 47.83 (-0.95%)
Sanofi (SNY) Q4 2023 Earnings Call Transcript

SNY earnings call for the period ending December 31, 2023.

SNY : 47.83 (-0.95%)
It's Almost 2024: 3 Top Stocks to Buy Before the New Year

You can pick these players up for a great price right now.

MSFT : 417.32 (+0.22%)
AMZN : 174.48 (+0.03%)
SNY : 47.83 (-0.95%)
KO : 60.13 (+0.42%)
GOOG : 148.48 (+4.44%)
GOOGL : 147.68 (+4.60%)
REGN : 959.92 (-0.47%)
3 Stocks to Buy Before 2024 That Can Set You Up For Life

These stocks are still relatively cheap, but don't expect them to stay that way for long.

SNY : 47.83 (-0.95%)
REGN : 959.92 (-0.47%)
CCL : 16.19 (-0.43%)
GOOG : 148.48 (+4.44%)
GOOGL : 147.68 (+4.60%)
2 Biotech Stocks You Can Buy and Hold for the Next Decade

These stocks aren't popular on the market right now, but investors shouldn't let that scare them off.

SNY : 47.83 (-0.95%)
GILD : 73.26 (-0.58%)
Informatica soars on its AI-powered data management cloud growth

Enterprise cloud data management software provider Informatica Co. (NASDAQ: INFA) saw its shares surge 23% on its impressive Q3 2023 earnings report. The compa

F : 12.18 (+1.00%)
PG : 161.21 (-0.11%)
INFA : 34.85 (+1.75%)
AMZN : 174.48 (+0.03%)
INTC : 42.71 (+0.16%)
SNYNF : 94.8900 (-2.18%)
SNY : 47.83 (-0.95%)
SAN : 4.46 (+0.90%)
SHEL : 66.14 (+0.43%)
SHEL.LN : 2,560.500 (+0.47%)
RTX : 93.46 (+0.57%)
MarketBeat Week in Review – 11/6 - 11/10

Stocks closed the week with a strong rally, but the rally may reverse when investors get the latest information about inflation and retail stocks next week

FSLY : 12.73 (+1.03%)
PFE : 27.72 (-0.79%)
SNY : 47.83 (-0.95%)
RIVN : 11.40 (+3.26%)
NVDA : 884.55 (+0.70%)
QCOM : 166.92 (-0.17%)
BIRK : 46.40 (-1.47%)
VRTX : 411.38 (+0.91%)
ABNB : 161.86 (+0.76%)
INTC : 42.71 (+0.16%)
LYV : 104.38 (+0.59%)
PLTR : 24.00 (+2.17%)
Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time

There are very good reasons that stocks generally gain in value after a company receives %OrphanDrug designation (ODD). A study published in Orphanet Journal of Rare Diseases showed that the average stock...

SNY : 47.83 (-0.95%)
TAK : 14.56 (+0.62%)
NRX.VN : 0.720 (-8.86%)
BMY : 51.59 (-1.43%)
NRX : 0.14 (+7.69%)
Pfizer and Sanofi shares fall, which one to scoop up?

Pharmaceutical stocks aren't having a banner year; notably, two large pharmaceutical companies recently plunged to 52-week lows

PFE : 27.72 (-0.79%)
SNY : 47.83 (-0.95%)
SNYNF : 94.8900 (-2.18%)
SAN : 4.46 (+0.90%)
MDCO : 84.90 (-0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sanofi-Aventis manufactures & markets prescription drugs across countries. It focuses on major therapeutic areas such as multiple sclerosis, cardiovascular, immunology, neurology, oncology, rare blood disorders & diabetes, etc. By taking Genzyme Corporation as a subsidiary, it added products like Cerezyme,...

See More

Key Turning Points

3rd Resistance Point 48.43
2nd Resistance Point 48.28
1st Resistance Point 48.05
Last Price 47.83
1st Support Level 47.67
2nd Support Level 47.52
3rd Support Level 47.29

See More

52-Week High 57.82
Fibonacci 61.8% 52.02
Fibonacci 50% 50.22
Fibonacci 38.2% 48.43
Last Price 47.83
52-Week Low 42.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar